Gencor and Pharmako Biotechnologies have announced the latest liposome tech with its scientifically proven PlexoZome technology. PlexoZome is an advanced targeted delivery liposomal technology for liquid formulations uniquely developed and made on-site in its licensed facility for fully customisable and stable liposomal ingredients.
“By nature, many supplement ingredients require high doses and have slow onsets of action. As both brands and consumers recognise this, in addition to consumers wanting more convenient solutions, they seek ingredients with enhanced bioavailability,” said Geroge Kokkinis, Technical Director at Pharmako Biotechnologies. “Because of PlexoZome, a specialised technology now exists to create technically advanced structured vesicles. This structure and characteristics provide genuine liposomes with special targeted delivery advantages that are scientifically verified.”
Because of PlexoZome, a specialised technology now exists to create technically advanced structured vesicles
Liposomes are tiny complex structures surrounded by a lipid bilayer membrane and are not visible with a standard light microscope. The presence of PlexoZomes formulations is verified through Transmission Electron Microscopy (TEM) and Cryo-TEM imaging, the only way to view the liposome structure and their bilayer membrane structure. Made in Pharmako’s TGA-licensed facility adhering to strict GMP protocols, PlexoZome also offers increased stability and customised particle size with Dynamic Light Scattering (DLS) validation.
“Many liposomal supplements are nothing more than phospholipid emulsions, which cannot offer the true absorption benefits of genuine liposomal formulations,” said R.V. Venkatesh, Co-Founder of Gencor. “We have worked diligently to develop a scientifically proven complex liposomal technology for enhanced stability, absorption, and customisation to bring better wellness solutions to more people.”
Readily available PlexoZome formulations include:
- Vitamin B12
- Vitamin D3
- Hyaluronic acid
- Phospholipids – Phosphatidylcholine
- Nicotinamide riboside (NR)
“We have the capabilities to customise any ingredient with this liposomal technology, giving endless possibilities for manufacturers,” Venkatesh added.